- NEWS
Quarter-dose of Moderna COVID vaccine still rouses a big immune response
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-021-01893-0
References
Mateus, J. et al. Preprint at medRxiv https://doi.org/10.1101/2021.06.30.21259787 (2021).
Casey, R. M. et al. N. Engl. J. Med. 381, 444–454 (2019).
Jackson, L. A. et al. N. Engl. J. Med. 383, 1920–1931 (2020).
Chu, L. et al. Vaccine 39, 2791–2799 (2021).
Cowling, B. J. et al. Nature Med. https://doi.org/10.1038/s41591-021-01440-4 (2021).
Więcek, W. et al. Preprint at SSRN https://doi.org/10.2139/ssrn.3864485 (2021).
How can countries stretch COVID vaccine supplies? Scientists are divided over dosing strategies
‘Unprecedented achievement’: who received the first billion COVID vaccinations?
Is one vaccine dose enough if you’ve had COVID? What the science says
Mounting evidence suggests Sputnik COVID vaccine is safe and effective
Six months of COVID vaccines: what 1.7 billion doses have taught scientists
